Hunter Robinson represents clients in commercial litigation and compliance-related matters across the country. His litigation practice focuses on representing financial institutions in lender-liability, title, and business disputes, including class actions. Hunter represents mortgage servicers and lenders in suits arising from repurchase demands, and defends those entities in litigation involving alleged violations of the Truth in Lending Act (TILA), Fair Debt Collection Practices Act (FDCPA), Real Estate Settlement Procedures Act (RESPA), and the Fair Credit Reporting Act (FCRA), and common-law claims for breach of contract, breach of fiduciary duty, and fraud.
Hunter leverages his experience representing highly-regulated businesses to solve problems for cannabis companies and the vendors that serve them. In this role, he provides compliance advice to financial institutions regarding the complex laws governing the provision of financial services to cannabis companies, including the Bank Secrecy Act (BSA) and related Anti-Money Laundering (AML) statutes and regulations. Hunter also assists hemp and cannabidiol (CBD) companies with a variety of issues, including entity formation and structuring, raising capital, regulatory compliance, and business disputes.
More Legal and Business Bylines From J. Hunter Robinson
- Warning Sign? A New Round of FDA Warning Letters Over CBD Consumer Confusion May Signal a Shift in Government Enforcement - (Posted On Tuesday, December 13, 2022)
- Editors’ Roundtable: A New Biden Doctrine? - (Posted On Monday, October 31, 2022)
- Change (May) Come at Last? Biden Announces Review of Marijuana Scheduling and Mass Pardons for Simple Marijuana Possession - (Posted On Thursday, October 06, 2022)
- Editors’ Roundtable: The Southern Cannabis Market - (Posted On Wednesday, October 05, 2022)
- Editors’ Roundtable: When Will Marijuana Be Federally Legal and What Will That Look Like? - (Posted On Wednesday, July 27, 2022)
- Cannabis Banking: Will the SAFE Banking Act Finally Pass? - (Posted On Tuesday, June 21, 2022)
- Letter from the Editors: What a Long, Strange Trip It’s Been - (Posted On Friday, April 22, 2022)
- Tennessee Lawmakers to Consider Multiple Cannabis Proposals - (Posted On Tuesday, January 18, 2022)
- Planting the Seeds: The Present State and Potential Prospects of Medical Cannabis in Tennessee - (Posted On Wednesday, January 12, 2022)
- Same As It Ever Was: FDA Reiterates That CBD Cannot Be Included in Food or Dietary Supplements - (Posted On Wednesday, December 01, 2021)
The Cannabis Industry Team at Bradley Arant Boult Cummings has been selected for a Go-To Thought Leadership Award by the National Law Review. In the past year, various authors have covered the medical cannabis industry in Alabama, including cultivation, processing, and dispensing, as well as the SAFE Banking Act as it pertains to cannabis. Regular contributors under these topics include Whitt Steineker, James W. Wright, Jr., Shelby D. Lomax, J. Hunter Robinson, and Richard W.F. Swor.
The Cannabis Industry Team at Bradley Arant Boult Cummings LLP has been named a Go-To Thought Leader by the National Law Review. Over the span of 2022, the team has provided substantial insight into cannabis legalization at the state level, including updates for Alabama, North Carolina, Tennessee, and others. Regular contributing authors include (but are not limited to): Whitt Steineker, James W. Wright, Jr., Slates C. Veazey, Rachel M. LaBruyere, Elizabeth R. Hobbs, J. Hunter Robinson, and Claire Fox Hodge.